Sargeant et al (PI Davies)_SEESAW EASD 2020 abstract_physical activity.pdf (292.45 kB)
Effects of empagliflozin, diet, or both on physical activity and sedentary behaviour in people with type 2 diabetes: analyses from the SEESAW trial
conference contribution
posted on 2020-10-13, 09:16 authored by Jack A Sargeant, James A King, Emma L Baldry, Danielle H Bodicoat, Charlotte L Edwardson, Kamlesh Khunti, David J Stensel, David R Webb, John P H Wilding, Tom Yates, Melanie J DaviesConference abstract
Funding
Boehringer Ingelheim investigator-initiated grant and in-kind support from NIHR Leicester BRC
History
Citation
Diabetologia 63, 1–485 (2020). https://doi.org/10.1007/s00125-020-05221-5Source
56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)Version
- AM (Accepted Manuscript)
